MAQUET Cardiovascular Awarded Three-Year Contract | MAQUET Cardiovascular LLC
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News MAQUET Cardiovascular LLC MAQUET Cardiovascular Awarded Three-Year Contract

MAQUET Cardiovascular Awarded Three-Year Contract

Company News - MAQUET Cardiovascular LLC

MAQUET Cardiovascular signed a three-year contract with Novation to provide all of its cardiopulmonary (perfusion) products to the members of VHA Inc., UHC and Provista.

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, announced that it has signed a three-year contract with Novation, the industry's leading supply contracting company, to provide all of its cardiopulmonary (perfusion) products to the members of VHA Inc., University HealthSystem Consortium (UHC) and Provista. The agreement becomes effective on January 1, 2010, and runs through December 31, 2012. MAQUET Cardiovascular's cardiopulmonary products are used in on-pump cardiac surgery and include heart-lung machines, the QUADROX-i family of generators, the ROTAFLOW Centrifugal Pump, the MECC (Minimized Extracorporeal Circulation) System, the PLEGIOX Cardioplegia Heat Exchanger, standard or customized tubing packs and a full line of adult, pediatric and ECMO cannulae.

"This agreement represents an important milestone for MAQUET Cardiovascular as it is our first GPO contract for cardiopulmonary products in the United States and underscores the value of our products to surgeons and perfusionists," said Raoul Quintero, President of MAQUET Cardiovascular U.S. Sales LLC. "We are committed to supporting positive patient outcomes and are pleased that members will now have access to our full range of innovative perfusion products, as well as our surgical devices for beating heart cardiac surgery and our market-leading VASOVIEW Endoscopic Vessel Harvesting (EVH) Systems through two contracts we signed with Novation previously."

"Novation continues to provide members of VHA, UHC and Provista with the most advanced technology, best customer service and preferred pricing. We found that MAQUET Cardiovascular's cardiopulmonary product portfolio met the requirements of our rigorous contracting review process," said Scott Crandall, Senior Director, Contract Services Cardiology at Novation. "We are pleased that this is the third agreement we have signed this year with MAQUET Cardiovascular."

Source: MAQUET Cardiovascular

You can discuss about MAQUET Cardiovascular and its services in the MAQUET Cardiovascular Company User Group